Skip to content

Actinium Pharmaceuticals, Inc.

ATNM· NYSECore metricsCIK 1388320

Pharmaceutical preparations552 peers

Last sale
Nov 2, 2026 · -4.36%
Market cap
$44.80M
31.44M shares
Filings
512
$35.00M
Q3 2026+11.1% FY25 yoy
-$5.84M
Q3 2026N/M FY25 yoy
-$6.12M
Q3 2026N/M FY25 yoy
-$19.32M
Q3 2026derivedN/M FY25 yoy
-$0.19
Q3 2026N/M FY25 yoy
$28.68M
Q3 2026−34.2% FY25 yoy
$44.80M
—
497.8×
1.8×
-55.09%
—

FY2025 figures · derived

Price

$1.43+4.01%+$0.05past year
Nov 2, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$90.00KFY 2025
$1.14M0FY 2010FY 2011FY 2021FY 2022FY 2023FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$90,000reported
FY 20232023-12-31$81,000reported
FY 20222022-12-31$1,030,000reported
FY 20212021-12-31$1,144,000reported
FY 20112011-12-31$0reported
FY 20102010-12-31$0reported

Pharmaceutical preparations

Actinium Pharmaceuticals, Inc. is the 243rd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR